This document discusses various abnormalities seen on electrocardiograms related to enlargement of the heart's chambers and thickening of the ventricular walls. It describes how right and left atrial enlargement manifest as changes to the P wave, including tall, wide P waves in specific leads. Right and left ventricular hypertrophy are described by their characteristic patterns in the right and left chest leads, including tall R waves and deep S waves. Common causes of each type of cardiac abnormality are provided.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
This document is designed as an introductory to medical students,nursing students,midwives or other healthcare trainees to improve their understanding about how health system in Sri Lanka cares children health.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
2. CARDIAC ENLARGEMENT
1. DILATION
a. STRETCHED
b. E.G. CONGESTIVE HEART FAILURE
2. HYPERTROPHY
a. INCREASE SIZE OF HEART MUSCLE FIBERS
b. E.G. AORTIC STENOSIS
3. RIGHT ATRIAL ABNORMALITY
• OVERLOAD OF THE RIGHT ATRIA
• DILATION
• HYPERTROPHY
• ALSO KNOWN AS P PULMONALE
• HOW WOULD THIS CHANGE THE P WAVE?
4. RIGHT ATRIAL ABNORMALITY
• NORMAL P WAVE IS LESS THAN 2.5 MM TALL AND 0.10 SECONDS WIDE.
• WITH RIGHT ATRIAL HYPERTROPHY, P WAVES ARE TYPICALLY TALLER
THAN 2.5 MM BUT NOT WIDER THAN 0.10SEC.
7. LEFT ATRIAL ABNORMALITY
•ALSO KNOWN AS P MITRALE
•LEFT ATRIA NORMALLY DEPOLARIZES AFTER THE RIGHT
ATRIA.
•HOW WOULD THIS AFFECT THE P WAVE?
•WIDER; LEFT ATRIAL ENLARGEMENT SHOULD PROLONG THE
P WAVE > 0.10 SEC.
10. LEFT ATRIAL ABNORMALITY
• LEAD II (AND I) SHOW
WIDE P WAVES
• (SECOND HUMP DUE TO
DELAYED
DEPOLARIZATION OF THE
LEFT ATRIUM)
• (P MITRALE: MITRAL
VALVE DISEASE)
• V1 MAY SHOW A BI-
PHASIC P WAVE
• 1 BOX WIDE, 1 BOX DEEP
• (BIPHASIC SINCE RIGHT
ATRIA IS ANTERIOR TO
THE LEFT ATRIA)
17. RIGHT VENTRICULAR HYPERTROPHY
CRITERIA
1.IN V1, R WAVE IS GREATER THAN THE S WAVE - OR - R
IN V1 GREATER THAN 7 MM
1. RIGHT AXIS DEVIATION
2. IN V1, T WAVE INVERSION (REASON UNKNOWN)
3. S WAVES IN V5 AND V6
18. RIGHT VENTRICULAR HYPERTROPHY
• CAUSES OF RVH
• PULMONARY DISEASE
• CONGENITAL HEART DISEASE
• (EMPHYSEMA MAY MASK SIGNS OF RVH)
• POSTERIOR WALL MI MAY ALSO SHOW TALL R WAVES IN V1
20. Fig 6.9
R wave in V1.
P waves in II, III, & V1
T wave inversion
PR interval
21. LEFT VENTRICULAR HYPERTROPHY
• WITH LVH, THE ELECTRICAL BALANCE IS TIPPED EVEN FURTHER TO THE
LEFT.
• TALL R WAVES IN THE LEFT CHEST LEADS
• PREDOMINATE S WAVES IN THE RIGHT CHEST LEADS
23. LEFT VENTRICULAR
HYPERTROPHY CRITERIA
•SOKOLOW-LYON VOLTAGE CRITERIA
•IF S WAVE IN V1 + R WAVE IN V5 OR V6 ≥
35 MM (≥ 50 FOR UNDER 35 YRS OF
AGE)
•R WAVE > 11 MM IN AVL OR I...
•ALSO
•LVH IS MORE LIKELY WITH A “STRAIN PATTERN”
OR ST SEGMENT CHANGES
•LEFT AXIS DEVIATION
•LEFT ATRIAL ABNORMALITY
24. LEFT VENTRICULAR HYPERTROPHY
• CAUSES:
• HYPERTENSION
• AORTIC STENOSIS
• NOT ALWAYS PATHOLOGICAL
• RISKS OF LVH
• CONGESTIVE HEART FAILURE
• ARRHYTHMIAS
25. LEFT VENTRICULAR HYPERTROPHY
• HIGH VOLTAGE CAN BE SEEN IN NORMAL PEOPLE, ESPECIALLY ATHLETES
• WITH HYPERTROPHY IN BOTH VENTRICLES, THE ECG WILL SHOW MORE
EVIDENCE OF LVH
36. Tall R waves in V4 and V5 with down sloping ST segment depression and T wave inversion are
suggestive of left ventricular hypertrophy (LVH) with strain pattern. LVH with strain pattern usually
occurs in pressure overload of the left ventricle as in systemic hypertension or aortic stenosis.
Similar pattern may also occur in long standing severe aortic regurgitation, though the usual pattern
in aortic regurgitation is left ventricular volume overload.
Negative P waves in lead V1 is indicative of left atrial overload. Shallow T wave inversions are seen
in inferior leads. Two supra ventricular ectopic beats are also seen in the rhythm strip. They are
characterized by their premature nature, a P wave of different morphology preceding the QRS (in this
case merging with the T wave of the previous beat), narrow QRS complex and an incomplete
compensatory pause.
37. Right atrial overload (P pulmonale) and right ventricular hypertrophy. Right atrial overload (enlargement) is
manifest as tall sharp P waves in lead II and V1. The cut off values are P wave amplitude more than 0.25 mV in lead II
and 0.1 mV or more in V1. Dominant R waves in V1 and deep S waves in V6 indicate right ventricular hypertrophy (RVH).
Sokolow-Lyon for RVH criteria mentions that R wave in V1 + S wave in V5/V6 should be 1.1 mV or more. There is also a
clockwise rotation in the QRS pattern between V1 to V6. QRS axis is around +120 degrees (aVR biphasic and lead III
showing tallest QRS complex). Right axis deviation is also due to right ventricular hypertrophy. T wave inversion in inferior
leads and V1 could be due to right ventricular hypertrophy itself. RVH in this case is type A with dominant R in V1 and
deep S in V6. This type is seen in pulmonary stenosis. Type B RVH shows dominant R waves in V1 without deep S in V6.
Deep S in V6 without dominant R in V1 seen in chronic obstructive lung disease with cor-pulmonale is called type C RVH.
(Strictly speaking the types are classified depending upon vector cardiographic features and not based on scalar ECG)